AKTX vs AMGN: Which Stock is Better?
Side-by-side comparison of Akari Therapeutics Plc and Amgen Inc in 2026
AKTX
Akari Therapeutics Plc
$0.16
AMGN
Amgen Inc
$351.48
Key Metrics Comparison
| Metric | AKTX | AMGN | Winner |
|---|---|---|---|
| Market Cap | $16.96M | $194.67B | AMGN |
| P/E Ratio | N/A | 25.38 | AMGN |
| EPS (TTM) | $N/A | $14.23 | AMGN |
| Revenue Growth | 0.0% | 0.1% | AMGN |
| Gross Margin | 0.0% | 70.8% | AMGN |
Analyze AKTX
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is AKTX or AMGN a better investment?
Comparing AKTX and AMGN: Akari Therapeutics Plc has a market cap of $16.96M while Amgen Inc has $194.67B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between AKTX and AMGN?
AKTX (Akari Therapeutics Plc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: AKTX or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: AKTX or AMGN?
AMGN has higher revenue growth at 0.1% vs 0.0% for AKTX.
Which company is more profitable: AKTX or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to 0.0% for AKTX.
Which is the larger company: AKTX or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $194.67B compared to $16.96M for AKTX.
Should I buy AKTX or AMGN in 2026?
Both AKTX and AMGN have investment merit. AKTX trades at $0.16 while AMGN trades at $351.48. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between AKTX and AMGN stock?
Key differences: Market Cap ($16.96M vs $194.67B), P/E Ratio (N/A vs 25.4x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 70.8%).